Clinical trial
Gene Therapy in Treating Patients With Primary Brain Tumors
NCT00002824 · Abramson Cancer Center at Penn Medicine, Other · Completed
Key facts
| NCT number | NCT00002824 |
|---|---|
| Title | Gene Therapy in Treating Patients With Primary Brain Tumors |
| Official title | A PHASE I TRIAL OF HSV-TK ADENOVIRUS GENE THERAPY FOR PRIMARY BRAIN TUMORS |
| Lead sponsor | Abramson Cancer Center at Penn Medicine, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Biological, Drug, Procedure |
| Interventions | gene therapy, chemotherapy, ganciclovir, conventional surgery |
| Start date | Feb 1, 1996 |
| First posted | Jul 29, 2004 |
| Last update posted | Mar 13, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: